GILD
Gilead Sciences Inc
Price:  
69.96 
USD
Volume:  
4,927,890.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

Gilead WACC - Weighted Average Cost of Capital

The WACC of Gilead Sciences Inc (GILD) is 7.5%.

The Cost of Equity of Gilead Sciences Inc (GILD) is 8.65%.
The Cost of Debt of Gilead Sciences Inc (GILD) is 4.35%.

Range Selected
Cost of equity 7.20% - 10.10% 8.65%
Tax rate 20.20% - 22.90% 21.55%
Cost of debt 4.00% - 4.70% 4.35%
WACC 6.3% - 8.6% 7.5%
WACC

Gilead WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.72 0.92
Additional risk adjustments 0.0% 0.5%
Cost of equity 7.20% 10.10%
Tax rate 20.20% 22.90%
Debt/Equity ratio 0.29 0.29
Cost of debt 4.00% 4.70%
After-tax WACC 6.3% 8.6%
Selected WACC 7.5%